SCHEMBL20161001

SCHEMBL20161001

c1ccc(-c2ccc(-c3c(-c4ccccc4)c(-c4ccccc4)c(-c4ccc(-c5ccccc5)cc4)c(-c4ccc(-n5c6ccccc6c6cccnc65)cc4)c3-c3ccc(-c4ccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
ATM Q13315 2/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FEN1 P39748 1/20 0.39
KMT2A Q03164 4/20 0.37
ABCG2 Q9UNQ0 1/20 0.36
PDE4A P27815 4/20 0.36
PDE4B Q07343 4/20 0.36
PDE4C Q08493 4/20 0.36
PDE4D Q08499 4/20 0.36
MAPT P10636 2/20 0.36
PTK2B Q14289 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.35
HSP90AA1 P07900 1/20 0.35
HDAC4 P56524 1/20 0.34
DHODH Q02127 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17124118 0.95 ALDH1A1 (0.50) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL30804919 0.89 ALDH1A1 (0.45) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL29183657 0.89 ALDH1A1 (0.45) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL21397965 0.88 ALDH1A1 (0.47) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL22143424 0.87 ALDH1A1 (0.43) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL17349257 0.86 ALDH1A1 (0.49) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL17349450 0.86 ALDH1A1 (0.49) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL20161193 0.86 ALDH1A1 (0.42) ALDH1A1TSHRCYP2C19L3MBTL1FEN1
SCHEMBL261813 0.86 KDM4E (0.47) ALDH1A1TSHRCYP2C19ATMKDM4E
SCHEMBL23626743 0.86 ALDH1A1 (0.44) ALDH1A1TSHRCYP2C19ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
EP-4271163-A2 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP Merck Patent GmbH (DE) 2023-11-01 EP disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-20200203624-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2020-06-25 US disclosed
WO-2018087346-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11711976-B2 Compounds with an acceptor and a donor group NQO1, ICMT, NUDT1 ALDH1A1 242/4885TSHR 4702/4885CYP2C19 303/4885
US-20200203624-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 ALDH1A1 242/4885TSHR 4702/4885CYP2C19 303/4885
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 ALDH1A1 242/4885TSHR 4702/4885CYP2C19 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.